|
|
|||||||||
|
|
NeoReviews Vol.8 No.5 2007 e214
© 2007 American Academy of Pediatrics
* Divisions of Neonatology, Clinical Pharmacology and Toxicology, The Pediatric Pharmacology Research Unit Network (PPRU) at Wayne State University, Children's Hospital of Michigan, Detroit, Mich
Caffeine is used commonly in the neonatal intensive care unit to treat apnea of prematurity. This review describes the mechanism of action, pharmacokinetics, and therapeutic role of caffeine. Published data on its efficacy and safety document that caffeine can reduce the frequency of apneic episodes and appears safe in the short term.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |